Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|December 9, 2015
Continuous event monitoring via a Bayesian predictive approachJianing Di, Daniel Wang, H Robert Brashear, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III StudiesH Robert Brashear, Nzeera Ketter, Jennifer Bogert, et al.
JB & JS Open Access|September 20, 2018
A Patient-Focused Technology-Enabled Program Improves Outcomes in Primary Total Hip and Knee Replacement SurgeryPrakash Jayakumar, Jianing Di, Jiayu Fu, et al.
Journal of Alzheimer'S Disease : JAD|March 9, 2017
Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease PatientsNzeera Ketter, H Robert Brashear, Jennifer Bogert, et al.
Journal of Alzheimer'S Disease : JAD|September 3, 2016
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's diseaseMark Brody, Enchi Liu, Jianing Di, et al.
Obesity Surgery|June 29, 2014
Effects of meal size on the release of GLP-1 and PYY after Roux-en-Y gastric bypass surgery in obese subjects with or without type 2 diabetesWen Yan, David Polidori, Lynn Yieh, et al.
Journal of Alzheimer'S Disease : JAD|December 8, 2015
Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's DiseaseGerald Novak, Nick Fox, Shona Clegg, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
The Dynamics of Cognitive Decline towards Alzheimer's Disease Progression: Results from ADSP-PHC's Harmonized Cognitive CompositesKaidi Kang, Panpan Zhang, Logan Dumitrescu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 20, 2025
The dynamics of cognitive decline toward Alzheimer's disease progression: Results from ADSP-PHC's harmonized cognitive compositesKaidi Kang, Panpan Zhang, Logan Dumitrescu, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2012
Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorderPascal Bonaventure, Christine Dugovic, Michelle Kramer, et al.
Pageof 2